{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T09:09:04Z","timestamp":1793351344416,"version":"4.5.0"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0445-5","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T07:51:55Z","timestamp":1487577115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["Non anti-coagulant factors associated with filter life in continuous renal replacement therapy (CRRT): a systematic review and meta-analysis"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3290-826X","authenticated-orcid":false,"given":"Matthew","family":"Brain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Winson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Owen","family":"Roodenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,20]]},"reference":[{"key":"445_CR1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/cc5937","volume":"11","author":"M Joannidis","year":"2007","unstructured":"Joannidis M, Oudemans-van Straaten HM. Clinical review: patency of the circuit in continuous renal replacement therapy. Crit Care. 2007;11:218.","journal-title":"Crit Care"},{"key":"445_CR2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000102081","volume":"156","author":"I Baldwin","year":"2007","unstructured":"Baldwin I. Factors affecting circuit patency and filter \u201clife\u201d. Contrib Nephrol. 2007;156:178\u201384.","journal-title":"Contrib Nephrol"},{"key":"445_CR3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S1036-7314(06)80026-3","volume":"19","author":"H Davies","year":"2006","unstructured":"Davies H, Leslie G. Maintaining the CRRT circuit: non-anticoagulant alternatives. Aust Crit Care. 2006;19:133\u20138.","journal-title":"Aust Crit Care"},{"key":"445_CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.aucc.2006.11.001","volume":"20","author":"H Davies","year":"2007","unstructured":"Davies H, Leslie G. Anticoagulation in CRRT: agents and strategies in Australian ICUs. Aust Crit Care. 2007;20:15\u201326.","journal-title":"Aust Crit Care"},{"key":"445_CR5","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/cc9358","volume":"15","author":"HM Oudemans-van Straaten","year":"2011","unstructured":"Oudemans-van Straaten HM, Kellum JA, Bellomo R. Clinical review: anticoagulation for continuous renal replacement therapy-heparin or citrate? Crit Care. 2011;15:202.","journal-title":"Crit Care"},{"key":"445_CR6","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1053\/j.ajkd.2011.11.030","volume":"59","author":"M-Y Wu","year":"2012","unstructured":"Wu M-Y, Hsu Y-H, Bai C-H, Lin Y-F, Wu C-H, Tam K-W. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis. 2012;59:810\u20138.","journal-title":"Am J Kidney Dis"},{"key":"445_CR7","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1007\/s00134-015-4099-0","volume":"41","author":"M Bai","year":"2015","unstructured":"Bai M, Zhou M, He L, Ma F, Li Y, Yu Y, et al. Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med. 2015;41:2098\u2013110.","journal-title":"Intensive Care Med"},{"key":"445_CR8","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008\u201312.","journal-title":"JAMA"},{"key":"445_CR9","unstructured":"Google Translate [Internet]. [cited 2016 Mar 4]. Available from: https:\/\/translate.google.com.au\/ ."},{"key":"445_CR10","unstructured":"Borenstein, Michael, Hedges, Larry, Higgins, Julian, Rothstein, Hannah. Comprehensive Meta-Analysis Software (CMA) [Internet]. [cited 2016 Mar 4]. Available from: https:\/\/www.meta-analysis.com\/ ."},{"key":"445_CR11","unstructured":"Review Manager (Revman) [Internet]. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration; 2014 [cited 2016 Mar 4]. Available from: http:\/\/tech.cochrane.org\/revman ."},{"key":"445_CR12","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1037\/1082-989X.8.4.492","volume":"8","author":"R Rosenthal","year":"2003","unstructured":"Rosenthal R, Rubin DB. r-sub(equivalent): a simple effect size indicator. Psychol Methods. 2003;8:492\u20136.","journal-title":"Psychol Methods"},{"key":"445_CR13","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3102\/1076998610396901","volume":"37","author":"AM Aloe","year":"2012","unstructured":"Aloe AM, Becker BJ. An effect size for regression predictors in meta-analysis. J Educ Behav Stat. 2012;37:278\u201397.","journal-title":"J Educ Behav Stat"},{"key":"445_CR14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1037\/0021-9010.90.1.175","volume":"90","author":"RA Peterson","year":"2005","unstructured":"Peterson RA, Brown SP. On the use of beta coefficients in meta-analysis. J Appl Psychol. 2005;90:175\u201381.","journal-title":"J Appl Psychol"},{"key":"445_CR15","doi-asserted-by":"crossref","unstructured":"Liu Z, Rich B, Hanley JA. Recovering the raw data behind a non-parametric survival curve. Syst. Rev. [Internet]. 2014 [cited 2016 Feb 17];3. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4293001\/ .","DOI":"10.1186\/2046-4053-3-151"},{"key":"445_CR16","unstructured":"J Hanley: Data Recovery [Internet]. [cited 2016 Feb 17]. Available from: http:\/\/www.med.mcgill.ca\/epidemiology\/hanley\/software\/DataRecovery\/ ."},{"key":"445_CR17","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/sim.1303","volume":"21","author":"PR Williamson","year":"2002","unstructured":"Williamson PR, Smith CT, Hutton JL, Marson AG. Aggregate data meta-analysis with time-to-event outcomes. Stat Med. 2002;21:3337\u201351.","journal-title":"Stat Med"},{"key":"445_CR18","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8","volume":"17","author":"MKB Parmar","year":"1998","unstructured":"Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1998;17:2815\u201334.","journal-title":"Stat Med"},{"key":"445_CR19","unstructured":"Mitchell, Mark. Engauge Digitizer [Internet]. 2014 [cited 2016 Feb 17]. Available from: http:\/\/digitizer.sourceforge.net\/ ."},{"key":"445_CR20","unstructured":"R. Core Team. R: A Language and Environment for Statistical Computing [Internet]. Vienna, Austria; 2013. Available from: http:\/\/www.R-project.org\/ ."},{"key":"445_CR21","unstructured":"Therneau T. A Package for Survival Analysis in S. R package [Internet]. Vienna, Austria; 2015. Available from: http:\/\/CRAN.R-project.org\/package=survival ."},{"key":"445_CR22","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions [Internet]. Version 5.1.0. The Cochrane Collaboration; 2011. Available from: www.cochrane-handbook.org ."},{"key":"445_CR23","first-page":"225","volume":"16","author":"WJ Dunn","year":"2014","unstructured":"Dunn WJ, Sriram S. Filter lifespan in critically ill adults receiving continuous renal replacement therapy: the effect of patient and treatment-related variables. Crit Care Resusc J Australas Acad Crit Care Med. 2014;16:225\u201331.","journal-title":"Crit Care Resusc J Australas Acad Crit Care Med"},{"key":"445_CR24","first-page":"127","volume":"16","author":"A Crosswell","year":"2014","unstructured":"Crosswell A, Brain MJ, Roodenburg O. Vascular access site influences circuit life in continuous renal replacement therapy. Crit Care Resusc J Australas Acad Crit Care Med. 2014;16:127\u201330.","journal-title":"Crit Care Resusc J Australas Acad Crit Care Med"},{"key":"445_CR25","unstructured":"Evidence Prime, Inc. GRADEpro GDT: GRADEpro Guideline Development Tool [Internet]. McMaster University; 2015 [cited 2016 Mar 4]. Available from: http:\/\/gradepro.org\/ ."},{"key":"445_CR26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/j.ajkd.2012.01.021","volume":"60","author":"D Morgan","year":"2012","unstructured":"Morgan D, Ho K, Murray C, Davies H, Louw J. A randomized trial of catheters of different lengths to achieve right atrium versus superior vena cava placement for continuous renal replacement therapy. Am J Kidney Dis Off J Natl Kidney Found. 2012;60:272\u20139.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"445_CR27","first-page":"131","volume":"16","author":"MJ Brain","year":"2014","unstructured":"Brain MJ, Roodenburg OS, Adams N, McCracken P, Hockings L, Musgrave S, et al. Randomised trial of software algorithm driven regional citrate anticoagulation versus heparin in continuous renal replacement therapy: the Filter Life in Renal Replacement Therapy pilot trial. Crit Care Resusc J Australas Acad Crit Care Med. 2014;16:131\u20137.","journal-title":"Crit Care Resusc J Australas Acad Crit Care Med"},{"key":"445_CR28","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/CCM.0b013e3181d454b3","volume":"38","author":"J-J Parienti","year":"2010","unstructured":"Parienti J-J, M\u00e9garbane B, Fischer M-O, Lautrette A, Gazui N, Marin N, et al. Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: a randomized controlled study. Crit Care Med. 2010;38:1118\u201325.","journal-title":"Crit Care Med"},{"key":"445_CR29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000439581","volume":"41","author":"R Bellomo","year":"2015","unstructured":"Bellomo R, M\u00e5rtensson J, Lo S, Kaukonen K-M, Cass A, Gallagher M, et al. Femoral access and delivery of continuous renal replacement therapy dose. Blood Purif. 2015;41:11\u20137.","journal-title":"Blood Purif"},{"key":"445_CR30","doi-asserted-by":"crossref","first-page":"e2392","DOI":"10.1097\/MD.0000000000002392","volume":"94","author":"J-Y Choi","year":"2015","unstructured":"Choi J-Y, Kang Y-J, Jang HM, Jung H-Y, Cho J-H, Park S-H, et al. Nafamostat Mesilate as an anticoagulant during continuous renal replacement therapy in patients with high bleeding risk: a randomized clinical trial. Medicine (Baltimore). 2015;94:e2392.","journal-title":"Medicine (Baltimore)"},{"key":"445_CR31","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00003246-200002000-00022","volume":"28","author":"AC Pont De","year":"2000","unstructured":"De Pont AC, Oudemans-van Straaten HM, Roozendaal KJ, Zandstra DF. Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: a double-blind, randomized, crossover study. Crit Care Med. 2000;28:421\u20135.","journal-title":"Crit Care Med"},{"key":"445_CR32","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1592\/phco.30.11.1117","volume":"30","author":"TH Kiser","year":"2010","unstructured":"Kiser TH, MacLaren R, Fish DN, Hassell KL, Teitelbaum I. Bivalirudin versus unfractionated heparin for prevention of hemofilter occlusion during continuous renal replacement therapy. Pharmacotherapy. 2010;30:1117\u201326.","journal-title":"Pharmacotherapy"},{"key":"445_CR33","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/j.1523-1755.2005.00342.x","volume":"67","author":"DJ Kutsogiannis","year":"2005","unstructured":"Kutsogiannis DJ, Gibney RTN, Stollery D, Gao J. Regional citrate versus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int. 2005;67:2361\u20137.","journal-title":"Kidney Int"},{"key":"445_CR34","doi-asserted-by":"crossref","first-page":"R193","DOI":"10.1186\/cc8191","volume":"13","author":"HM Oudemans-van Straaten","year":"2009","unstructured":"Oudemans-van Straaten HM, van Schilfgaarde M, Molenaar PJ, Wester JP, Leyte A. Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates. Crit Care Lond Engl. 2009;13:R193.","journal-title":"Crit Care Lond Engl"},{"key":"445_CR35","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/cc4853","volume":"10","author":"D Cheyron Du","year":"2006","unstructured":"Du Cheyron D, Bouchet B, Bruel C, Daubin C, Ramakers M, Charbonneau P. Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case\u2013control study. Crit Care Lond Engl. 2006;10:R45.","journal-title":"Crit Care Lond Engl"},{"key":"445_CR36","doi-asserted-by":"crossref","first-page":"R161","DOI":"10.1186\/cc14001","volume":"18","author":"YT Wang","year":"2014","unstructured":"Wang YT, Haines TP, Ritchie P, Walker C, Ansell TA, Ryan DT, et al. Early mobilization on continuous renal replacement therapy is safe and may improve filter life. Crit Care Lond Engl. 2014;18:R161.","journal-title":"Crit Care Lond Engl"},{"key":"445_CR37","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000322254","volume":"31","author":"IB Kim","year":"2011","unstructured":"Kim IB, Fealy N, Baldwin I, Bellomo R. Insertion side, body position and circuit life during continuous renal replacement therapy with femoral vein access. Blood Purif. 2011;31:42\u20136.","journal-title":"Blood Purif"},{"key":"445_CR38","first-page":"747","volume":"14","author":"T Mottes","year":"2013","unstructured":"Mottes T, Owens T, Niedner M, Juno J, Shanley TP, Heung M. Improving delivery of continuous renal replacement therapy: impact of a simulation-based educational intervention. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2013;14:747\u201354.","journal-title":"Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc"},{"key":"445_CR39","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1159\/000441968","volume":"41","author":"L Zhang","year":"2015","unstructured":"Zhang L, Tanaka A, Zhu G, Baldwin I, Eastwood GM, Bellomo R. Patterns and mechanisms of artificial kidney failure during continuous renal replacement therapy. Blood Purif. 2015;41:254\u201363.","journal-title":"Blood Purif"},{"key":"445_CR40","first-page":"22","volume":"9","author":"I Baldwin","year":"1996","unstructured":"Baldwin I, Bridge N, Heland M, Buckmaster J, Davies A, Hart G, et al. The effect of filter configuration on extracorporeal circuit life during continuous veno-venous haemofiltration. Aust Crit Care. 1996;9:22.","journal-title":"Aust Crit Care"},{"key":"445_CR41","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11255-014-0682-5","volume":"46","author":"X Fu","year":"2014","unstructured":"Fu X, Liang X, Song L, Huang H, Wang J, Chen Y, et al. Building and validation of a prognostic model for predicting extracorporeal circuit clotting in patients with continuous renal replacement therapy. Int Urol Nephrol. 2014;46:801\u20137.","journal-title":"Int Urol Nephrol"},{"issue":"Suppl 2","key":"445_CR42","first-page":"S65","volume":"89","author":"W Pichaiwong","year":"2006","unstructured":"Pichaiwong W, Leelahavanichkul A, Eiam-ong S. Efficacy of cellulose triacetate dialyzer and polysulfone synthetic hemofilter for continuous venovenous hemofiltration in acute renal failure. J Med Assoc Thail Chotmaihet Thangphaet. 2006;89 Suppl 2:S65\u201372.","journal-title":"J Med Assoc Thail Chotmaihet Thangphaet"},{"key":"445_CR43","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1007\/s00134-012-2633-x","volume":"38","author":"M Schetz","year":"2012","unstructured":"Schetz M, Van Cromphaut S, Dubois J, Van den Berghe G. Does the surface-treated AN69 membrane prolong filter survival in CRRT without anticoagulation? Intensive Care Med. 2012;38:1818\u201325.","journal-title":"Intensive Care Med"},{"key":"445_CR44","first-page":"343","volume":"27","author":"Y Yin","year":"2015","unstructured":"Yin Y, Zhao C, Hu Z, Wei S, Huo Y. The effect of AN69 ST membrane on filter lifetime in continuous renal replacement therapy without anticoagulation in patients with high risk of bleeding. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015;27:343\u20138.","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"445_CR45","first-page":"203637","volume":"2014","author":"F Bonassin Tempesta","year":"2014","unstructured":"Bonassin Tempesta F, Rudiger A, Previsdomini M, Maggiorini M. Platelet consumption and filter clotting using two different membrane sizes during continuous venovenous haemodiafiltration in the intensive care unit. Crit Care Res Pract. 2014;2014:203637.","journal-title":"Crit Care Res Pract"},{"key":"445_CR46","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/039139880803100305","volume":"31","author":"HT Davies","year":"2008","unstructured":"Davies HT, Leslie G, Pereira SM, Webb SA. R A randomized comparative crossover study to assess the affect on circuit life of varying pre-dilution volume associated with CVVH and CVVHDF. Int J Artif Organs. 2008;31:221\u20137.","journal-title":"Int J Artif Organs"},{"key":"445_CR47","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1186\/cc4903","volume":"10","author":"Z Ricci","year":"2006","unstructured":"Ricci Z, Ronco C, Bachetoni A, D\u2019amico G, Rossi S, Alessandri E, et al. Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion. Crit Care Lond Engl. 2006;10:R67.","journal-title":"Crit Care Lond Engl"},{"key":"445_CR48","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/01.mat.0000227733.03278.5f","volume":"52","author":"A-CJM Pont De","year":"2006","unstructured":"De Pont A-CJM, Bouman CSC, Bakhtiari K, Schaap MCL, Nieuwland R, Sturk A, et al. Predilution versus postdilution during continuous venovenous hemofiltration: a comparison of circuit thrombogenesis. ASAIO J Am Soc Artif Intern Organs 1992. 2006;52:416\u201322.","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"445_CR49","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000083938","volume":"23","author":"PHJ Voort Van der","year":"2005","unstructured":"Van der Voort PHJ, Gerritsen RT, Kuiper MA, Egbers PHM, Kingma WP, Boerma EC. Filter run time in CVVH: pre- versus post-dilution and nadroparin versus regional heparin-protamine anticoagulation. Blood Purif. 2005;23:175\u201380.","journal-title":"Blood Purif"},{"key":"445_CR50","doi-asserted-by":"crossref","first-page":"744.e7","DOI":"10.1016\/j.jcrc.2012.08.016","volume":"27","author":"H-R Chua","year":"2012","unstructured":"Chua H-R, Baldwin I, Bailey M, Subramaniam A, Bellomo R. Circuit lifespan during continuous renal replacement therapy for combined liver and kidney failure. J Crit Care. 2012;27:744.e7\u2013744.e15.","journal-title":"J Crit Care"},{"key":"445_CR51","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa0902413","volume":"361","author":"RENAL Study Investigators (last)","year":"2009","unstructured":"RENAL Study Investigators (last). Intensity of Continuous Renal-Replacement Therapy in Critically Ill Patients. N Engl J Med. 2009;361:1627\u201338.","journal-title":"N Engl J Med"},{"key":"445_CR52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJMoa0802639","volume":"359","author":"PM Palevsky","year":"2008","unstructured":"Palevsky PM, Zhang JH, O\u2019connor TZ, Chertow GM, Crowley ST, Choudhury D, et al. ATN Study : Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359:7\u201320.","journal-title":"N Engl J Med"},{"key":"445_CR53","first-page":"55","volume":"53","author":"GV Ramesh Prasad","year":"2000","unstructured":"Ramesh Prasad GV, Palevsky PM, Burr R, Lesko JM, Gupta B, Greenberg A. Factors affecting system clotting in continuous renal replacement therapy: results of a randomized, controlled trial. Clin Nephrol. 2000;53:55\u201360.","journal-title":"Clin Nephrol"},{"key":"445_CR54","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000333838","volume":"33","author":"GM Eastwood","year":"2012","unstructured":"Eastwood GM, Peck L, Young H, Bailey M, Reade MC, Baldwin I, et al. Haemodynamic impact of a slower pump speed at start of continuous renal replacement therapy in critically Ill adults with acute kidney injury: a prospective before-and-after study. Blood Purif. 2012;33:52\u20138.","journal-title":"Blood Purif"},{"key":"445_CR55","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1036-7314(96)70325-9","volume":"9","author":"I Baldwin","year":"1996","unstructured":"Baldwin I, Bridge N, Heland M, Buckmaster J, Davies A, Hart G, et al. The effect of heparin administration site on extracorporeal circuit life during continuous veno-venous haemofiltration. Aust Crit Care. 1996;9:29.","journal-title":"Aust Crit Care"},{"key":"445_CR56","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/BF01709346","volume":"22","author":"GD Leslie","year":"1996","unstructured":"Leslie GD, Jacobs IG, Clarke GM. Proximally delivered dilute heparin does not improve circuit life in continuous venovenous haemodiafiltration. Intensive Care Med. 1996;22:1261\u20134.","journal-title":"Intensive Care Med"},{"key":"445_CR57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000342596","volume":"34","author":"I Baldwin","year":"2012","unstructured":"Baldwin I, Fealy N, Carty P, Boyle M, Kim I, Bellomo R. Bubble chamber clotting during continuous renal replacement therapy: vertical versus horizontal blood flow entry. Blood Purif. 2012;34:213\u20138.","journal-title":"Blood Purif"},{"key":"445_CR58","first-page":"193","volume":"43","author":"JH Reeves","year":"1997","unstructured":"Reeves JH, Seal PF, Voss AL, O\u2019Connor C. Albumin priming does not prolong hemofilter life. ASAIO J Am Soc Artif Intern Organs 1992. 1997;43:193\u20136.","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"445_CR59","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1365-2648.2004.03117.x","volume":"47","author":"CM Rickard","year":"2004","unstructured":"Rickard CM, Couchman BA, Hughes M, McGrail MR. Preventing hypothermia during continuous veno-venous haemodiafiltration: a randomized controlled trial. J Adv Nurs. 2004;47:393\u2013400.","journal-title":"J Adv Nurs"},{"key":"445_CR60","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5301\/IJAO.5000191","volume":"36","author":"SD Hwang","year":"2013","unstructured":"Hwang SD, Hyun YK, Moon SJ, Lee SC, Yoon SY. Nafamostat mesilate for anticoagulation in continuous renal replacement therapy. Int J Artif Organs. 2013;36:208\u201316.","journal-title":"Int J Artif Organs"},{"key":"445_CR61","first-page":"478","volume":"21","author":"AP Nagarik","year":"2010","unstructured":"Nagarik AP, Soni SS, Adikey GK, Raman A. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy. Saudi J Kidney Dis Transplant Off Publ Saudi Cent Organ Transplant Saudi Arab. 2010;21:478\u201383.","journal-title":"Saudi J Kidney Dis Transplant Off Publ Saudi Cent Organ Transplant Saudi Arab"},{"issue":"Suppl 1","key":"445_CR62","first-page":"S105","volume":"94","author":"S Panphanpho","year":"2011","unstructured":"Panphanpho S, Naowapanich S, Ratanarat R. Use of saline flush to prevent filter clotting in continuous renal replacement therapy without anticoagulant. J Med Assoc Thail Chotmaihet Thangphaet. 2011;94 Suppl 1:S105\u201310.","journal-title":"J Med Assoc Thail Chotmaihet Thangphaet"},{"key":"445_CR63","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000319001","volume":"30","author":"IB Kim","year":"2010","unstructured":"Kim IB, Fealy N, Baldwin I, Bellomo R. Premature circuit clotting due to likely mechanical failure during continuous renal replacement therapy. Blood Purif. 2010;30:79\u201383.","journal-title":"Blood Purif"},{"key":"445_CR64","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/MAT.0b013e31823fdf20","volume":"58","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Ni H, Lu B. Variables associated with circuit life span in critically ill patients undergoing continuous renal replacement therapy: a prospective observational study. ASAIO J Am Soc Artif Intern Organs 1992. 2012;58:46\u201350.","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"445_CR65","first-page":"17","volume":"16","author":"I Ghitescu","year":"2009","unstructured":"Ghitescu I, Copotoiu SM, Toma RS, Ghitescu VT, Copotoiu R. Mean filter life span in continuous veno-venous hemofiltration for septic patients. Jurnalul Roman Anestezie Ter Intensiv J Anaesth Intensive Care. 2009;16:17\u201322.","journal-title":"Jurnalul Roman Anestezie Ter Intensiv J Anaesth Intensive Care"},{"key":"445_CR66","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jhep.2009.05.028","volume":"51","author":"B Agarwal","year":"2009","unstructured":"Agarwal B, Shaw S, Shankar Hari M, Burroughs AK, Davenport A. Continuous renal replacement therapy (CRRT) in patients with liver disease: is circuit life different? J Hepatol. 2009;51:504\u20139.","journal-title":"J Hepatol"},{"key":"445_CR67","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1213\/ANE.0b013e31827ced39","volume":"116","author":"R Brunner","year":"2013","unstructured":"Brunner R, Leiss W, Madl C, Druml W, Holzinger U. Single-dose application of antithrombin as a potential alternative anticoagulant during continuous renal replacement therapy in critically ill patients with advanced liver cirrhosis: a retrospective data analysis. Anesth Analg. 2013;116:527\u201332.","journal-title":"Anesth Analg"},{"key":"445_CR68","first-page":"580","volume":"50","author":"G Zick","year":"2009","unstructured":"Zick G, Wilms C, Renders L, Schulz J, Frerichs A, Frerichs I, et al. Continuous renal replacement therapy with regional citrate anticoagulation in patients with liver failure - A prospective observational study. [German]. Anasthesiologie Intensivmed. 2009;50:580\u201391.","journal-title":"Anasthesiologie Intensivmed"},{"key":"445_CR69","first-page":"16","volume":"19","author":"CD Goonasekera","year":"2015","unstructured":"Goonasekera CD, Wang J, Bunchman TE, Deep A. Factors affecting circuit life during continuous renal replacement therapy in children with liver failure. Ther Apher Dial Off Peer-Rev J Int Soc Apher Jpn Soc Apher Jpn Soc Dial Ther. 2015;19:16\u201322.","journal-title":"Ther Apher Dial Off Peer-Rev J Int Soc Apher Jpn Soc Apher Jpn Soc Dial Ther"},{"key":"445_CR70","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1186\/s13054-015-1066-7","volume":"19","author":"T Slowinski","year":"2015","unstructured":"Slowinski T, Morgera S, Joannidis M, Henneberg T, Stocker R, Helset E, et al. Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study. Crit Care Lond Engl. 2015;19:349.","journal-title":"Crit Care Lond Engl"},{"key":"445_CR71","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5301\/JN.2011.8363","volume":"25","author":"RA Balogun","year":"2012","unstructured":"Balogun RA, Turgut F, Caldwell S, Abdel-Rahman EM. Regional citrate anticoagulation in critically ill patients with liver and kidney failure. J Nephrol. 2012;25:113\u20139.","journal-title":"J Nephrol"},{"key":"445_CR72","doi-asserted-by":"crossref","first-page":"R150","DOI":"10.1186\/cc5080","volume":"10","author":"CSC Bouman","year":"2006","unstructured":"Bouman CSC, de Pont A-CJM, Meijers JCM, Bakhtiari K, Roem D, Zeerleder S, et al. The effects of continuous venovenous hemofiltration on coagulation activation. Crit Care Lond Engl. 2006;10:R150.","journal-title":"Crit Care Lond Engl"},{"key":"445_CR73","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000424629","volume":"116","author":"I Stefanidis","year":"1995","unstructured":"Stefanidis I, H\u00e4gel J, Maurin N. Influence of coagulation parameters on filter running time during continuous venovenous hemofiltration. Contrib Nephrol. 1995;116:145\u20139.","journal-title":"Contrib Nephrol"},{"key":"445_CR74","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/cc6937","volume":"12","author":"S Lasocki","year":"2008","unstructured":"Lasocki S, Piednoir P, Ajzenberg N, Geffroy A, Benbara A, Montravers P. Anti-PF4\/heparin antibodies associated with repeated hemofiltration-filter clotting: a retrospective study. Crit Care Lond Engl. 2008;12:R84.","journal-title":"Crit Care Lond Engl"},{"key":"445_CR75","doi-asserted-by":"crossref","unstructured":"Toonstra AL, Zanni JM, Sperati CJ, Nelliot A, Mantheiy E, Skinner EH, et al. Feasibility and safety of physical therapy during continuous renal replacement therapy in the intensive care unit. Ann Am Thorac Soc. 2016;699\u2013704.","DOI":"10.1513\/AnnalsATS.201506-359OC"},{"key":"445_CR76","doi-asserted-by":"crossref","first-page":"c43","DOI":"10.1159\/000076398","volume":"96","author":"T Hryszko","year":"2004","unstructured":"Hryszko T, Brzosko S, Mazerska M, Malyszko J, Mysliwiec M. Risk factors of nontunneled noncuffed hemodialysis catheter malfunction. Nephron Clin Pract. 2004;96:c43\u20137.","journal-title":"Nephron Clin Pract"},{"key":"445_CR77","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1046\/j.1523-1755.2000.00439.x","volume":"58","author":"MJ Oliver","year":"2000","unstructured":"Oliver MJ, Callery SM, Thorpe KE, Schwab SJ, Churchill DN. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int. 2000;58:2543\u20135.","journal-title":"Kidney Int"},{"key":"445_CR78","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMoa1500964","volume":"373","author":"J-J Parienti","year":"2015","unstructured":"Parienti J-J, Mongardon N, M\u00e9garbane B, Mira J-P, Kalfon P, Gros A, et al. Intravascular complications of central venous catheterization by insertion site. N Engl J Med. 2015;373:1220\u20139.","journal-title":"N Engl J Med"},{"key":"445_CR79","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/ndt\/14.7.1710","volume":"14","author":"L Kairaitis","year":"1999","unstructured":"Kairaitis L. Outcome and complications of temporary haemodialysis catheters. Nephrol Dial Transplant. 1999;14:1710\u20134.","journal-title":"Nephrol Dial Transplant"},{"key":"445_CR80","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000185837","volume":"54","author":"GE Cimochowski","year":"1990","unstructured":"Cimochowski GE, Worley E, Rutherford WE, Sartain J, Blondin J, Harter H. Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron. 1990;54:154\u201361.","journal-title":"Nephron"},{"key":"445_CR81","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00003246-199501000-00011","volume":"23","author":"SJ Trottier","year":"1995","unstructured":"Trottier SJ, Veremakis C, O\u2019Brien J, Auer AI. Femoral deep vein thrombosis associated with central venous catheterization: results from a prospective, randomized trial. Crit Care Med. 1995;23:52\u20139.","journal-title":"Crit Care Med"},{"key":"445_CR82","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jcrc.2013.08.010","volume":"29","author":"M Lipcsey","year":"2014","unstructured":"Lipcsey M, Chua H-R, Schneider AG, Robbins R, Bellomo R. Clinically manifest thromboembolic complications of femoral vein catheterization for continuous renal replacement therapy. J Crit Care. 2014;29:18\u201323.","journal-title":"J Crit Care"},{"key":"445_CR83","first-page":"S142","volume":"66","author":"B Canaud","year":"1998","unstructured":"Canaud B, Leray-Moragues H, Leblanc M, Klouche K, Vela C, B\u00e9raud JJ. Temporary vascular access for extracorporeal renal replacement therapies in acute renal failure patients. Kidney Int Suppl. 1998;66:S142\u201350.","journal-title":"Kidney Int Suppl"},{"key":"445_CR84","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/01.CCM.0000060446.45080.C6","volume":"31","author":"P Rogiers","year":"2003","unstructured":"Rogiers P, Zhang H, Pauwels D, Vincent J-L. Comparison of polyacrylonitrile (AN69) and polysulphone membrane during hemofiltration in canine endotoxic shock: Crit. Care Med. 2003;31:1219\u201325.","journal-title":"Care Med"},{"key":"445_CR85","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jca.20291","volume":"26","author":"T F\u00fcl\u00f6p","year":"2011","unstructured":"F\u00fcl\u00f6p T, Cosmin A, Juncos LA. Recurring extracorporeal circuit clotting during continuous renal replacement therapy resolved after single-session therapeutic plasma exchange. J Clin Apheresis. 2011;26:214\u20135.","journal-title":"J Clin Apheresis"},{"key":"445_CR86","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2307\/1266635","volume":"8","author":"GEP Box","year":"1966","unstructured":"Box GEP. Use and abuse of regression. Technometrics. 1966;8:625\u20139.","journal-title":"Technometrics"},{"key":"445_CR87","doi-asserted-by":"crossref","unstructured":"Ramsay JO, Silverman BW. Applied functional data analysis: methods and case studies. Springer New York; 2002.","DOI":"10.1007\/b98886"},{"key":"445_CR88","first-page":"320","volume":"50","author":"CC Geddes","year":"1998","unstructured":"Geddes CC, Walbaum D, Fox JG, Mactier RA. Insertion of internal jugular temporary hemodialysis cannulae by direct ultrasound guidance--a prospective comparison of experienced and inexperienced operators. Clin Nephrol. 1998;50:320\u20135.","journal-title":"Clin Nephrol"},{"key":"445_CR89","unstructured":"Headley CM, Thompson CL, Carter M, Khan A, Wall BM. The role of real-time ultrasound and physical examination measurements in placement of cuffed-tunneled hemodialysis catheters. Nephrol Nurs J. 2004;31:407\u2009+\u2009."},{"key":"445_CR90","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/01.anes.0000268280.02529.88","volume":"107","author":"D Karakitsos","year":"2007","unstructured":"Karakitsos D, Saranteas T, Patrianakos AP, Labropoulos N, Karabinis A. Ultrasound-guided\u201c Low Approach\u201d femoral vein catheterization in critical care patients results in high incidence of deep vein thrombosis. Anesthesiology. 2007;107:181\u20132.","journal-title":"Anesthesiology"},{"key":"445_CR91","unstructured":"Brain MJ. Non Anti-Coagulant Factors Associated with Filter Life in Continuous Renal Replacement Therapy (CRRT): A systematic review and meta-analysis. Study Data [Internet]. [cited 2016 Dec 8]. Available from: https:\/\/dx.doi.org\/10.4225\/03\/5848bb75cfaf4 ."},{"key":"445_CR92","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.5301\/ijao.5000003","volume":"34","author":"I Kim","year":"2011","unstructured":"Kim I, Fealy N, Baldwin I, Bellomo R. A comparison of the NiagaraTM and Dolphin\u00ae catheters for continuous renal replacement therapy. Int J Artif Organs. 2011;34:1061\u20136.","journal-title":"Int J Artif Organs"},{"key":"445_CR93","doi-asserted-by":"crossref","first-page":"308","DOI":"10.3109\/0886022X.2012.757823","volume":"35","author":"N Fealy","year":"2013","unstructured":"Fealy N, Kim I, Baldwin I, Schneider A, Bellomo R. A comparison of the Niagara and Medcomp catheters for continuous renal replacement therapy. Ren Fail. 2013;35:308\u201313.","journal-title":"Ren Fail"},{"key":"445_CR94","doi-asserted-by":"crossref","first-page":"808320","DOI":"10.1155\/2014\/808320","volume":"2014","author":"C Sponholz","year":"2014","unstructured":"Sponholz C, Bayer O, Kabisch B, Wurm K, Ebert K, Bauer M, et al. Anticoagulation strategies in venovenous hemodialysis in critically ill patients: a five-year evaluation in a surgical intensive care unit. ScientificWorldJournal. 2014;2014:808320.","journal-title":"ScientificWorldJournal"},{"key":"445_CR95","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S0272-6386(12)80675-5","volume":"24","author":"PY Martin","year":"1994","unstructured":"Martin PY, Chevrolet JC, Suter P, Favre H. Anticoagulation in patients treated by continuous venovenous hemofiltration: a retrospective study. Am J Kidney Dis Off J Natl Kidney Found. 1994;24:806\u201312.","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"445_CR96","doi-asserted-by":"crossref","first-page":"c94","DOI":"10.1159\/000072492","volume":"94","author":"S Uchino","year":"2003","unstructured":"Uchino S, Fealy N, Baldwin I, Morimatsu H, Bellomo R. Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control. Nephron Clin Pract. 2003;94:c94\u20138.","journal-title":"Nephron Clin Pract"},{"key":"445_CR97","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1177\/039139880502801203","volume":"28","author":"M Egi","year":"2005","unstructured":"Egi M, Naka T, Bellomo R, Cole L, French C, Trethewy C, et al. A comparison of two citrate anticoagulation regimens for continuous veno-venous hemofiltration. Int J Artif Organs. 2005;28:1211\u20138.","journal-title":"Int J Artif Organs"},{"key":"445_CR98","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MAT.0b013e318201a599","volume":"57","author":"SA Nurmohamed","year":"2011","unstructured":"Nurmohamed SA, Jallah BP, Vervloet MG, Beishuizen A, Groeneveld ABJ. Predilution versus postdilution continuous venovenous hemofiltration: no effect on filter life and azotemic control in critically ill patients on heparin. ASAIO J Am Soc Artif Intern Organs 1992. 2011;57:48\u201352.","journal-title":"ASAIO J Am Soc Artif Intern Organs 1992"},{"key":"445_CR99","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1471-2369-14-232","volume":"14","author":"S Morabito","year":"2013","unstructured":"Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F, et al. Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid\u2013base status and phosphate supplementation needs. BMC Nephrol. 2013;14:232.","journal-title":"BMC Nephrol"},{"key":"445_CR100","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.annfar.2014.10.008","volume":"33","author":"M Page","year":"2014","unstructured":"Page M, Rimmel\u00e9 T, Prothet J, Christin F, Crozon J, Ber C-E. Impact of a program designed to improve continuous renal replacement therapy stability. Ann Fr Anesth\u00e8sie R\u00e8animation. 2014;33:626\u201330.","journal-title":"Ann Fr Anesth\u00e8sie R\u00e8animation"},{"key":"445_CR101","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/nicc.12230","volume":"22","author":"J Ede","year":"2016","unstructured":"Ede J, Dale A. Has the use of CVVHDF when compared to CVVH during CRRT affected the failed circuit life within a major teaching hospital: a service evaluation. Nurs Crit Care. 2016;22:52\u20137.","journal-title":"Nurs Crit Care"},{"key":"445_CR102","first-page":"1651","volume":"27","author":"FH Saner","year":"2012","unstructured":"Saner FH, Treckmann JW, Geis A, L\u00f6sch C, Witzke O, Canbay A, et al. Efficacy and safety of regional citrate anticoagulation in liver transplant patients requiring post-operative renal replacement therapy. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2012;27:1651\u20137.","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"key":"445_CR103","doi-asserted-by":"crossref","first-page":"845","DOI":"10.5301\/ijao.5000283","volume":"36","author":"S Morabito","year":"2013","unstructured":"Morabito S, Pistolesi V, Tritapepe L, Vitaliano E, Zeppilli L, Polistena F, et al. Continuous veno-venous hemofiltration using a phosphate-containing replacement fluid in the setting of regional citrate anticoagulation. Int J Artif Organs. 2013;36:845\u201352.","journal-title":"Int J Artif Organs"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0445-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T17:58:29Z","timestamp":1568829509000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0445-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,20]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["445"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0445-5","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,20]]},"article-number":"69"}}